2009
DOI: 10.1016/j.canlet.2008.10.038
|View full text |Cite
|
Sign up to set email alerts
|

Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(38 citation statements)
references
References 44 publications
1
36
0
Order By: Relevance
“…This suggests that eIF3m influences the expression of a designated subset of genes for cell proliferation and tumor progression by affecting the mRNA level. In addition, as Lim et al (2009) reported that MT2A silencing resulted in cell division cycle 25 homolog A (CDC25A) degradation and G1-arrest in breast cancer cells, we found that eIF3m silencing immediately decreased CDC25A from 24 h until 72 h (Figure 8). These results further support that eIF3m expression influences the cell cycle regulation.…”
Section: Identification Of Eif3m-associated Transcripts By Ribonomicsmentioning
confidence: 69%
See 1 more Smart Citation
“…This suggests that eIF3m influences the expression of a designated subset of genes for cell proliferation and tumor progression by affecting the mRNA level. In addition, as Lim et al (2009) reported that MT2A silencing resulted in cell division cycle 25 homolog A (CDC25A) degradation and G1-arrest in breast cancer cells, we found that eIF3m silencing immediately decreased CDC25A from 24 h until 72 h (Figure 8). These results further support that eIF3m expression influences the cell cycle regulation.…”
Section: Identification Of Eif3m-associated Transcripts By Ribonomicsmentioning
confidence: 69%
“…This suggests that eIF3m expression has an effect in regulating mRNA levels of a specific subset of genes associated with cell proliferation and tumor progression. Further support for this hypothesis is provided by the reduced expression of MT2A resulting from ubiquitindependent degradation of CDC25A, which is necessary for the progression from G1 to S phase of the cell cycle via ATM/Chk2 in a breast cancer model (Lim et al, 2009). Although HCT-116 colon cancer cells showed subG0/G1 arrest rather than G1 arrest and S phase reduction with CDC25A loss as it was reported (Tomko et al, 2009), we supposed that this difference came from the different cell property of HCT-116 from breast cancer cells, MCF-7 or MCF12.…”
Section: Discussionmentioning
confidence: 97%
“…In cultured human Chang (CCl-13) hepatocytes, cell proliferation is associated with a 3-5 fold increase of metallothionein [44]. Conversely, down-regulation of the metallothionein-2A gene causes cell cycle arrest in the G1 phase [45]. These findings suggest a function of metallothionein in controlling cellular Zn 2+ availability for the activation/inhibition of zinc proteins involved in cell proliferation.…”
Section: Discussionmentioning
confidence: 94%
“…18) More recently, silencing of the MT2A gene inhibited cell cycle progression in breast cancer cells. 19) MT2A mRNA expression was reduced in NHBE and DHBE (COPD) cells by SWCNT exposure. Therefore, the decrease in MT2A gene expression in the present study might have some consequence on the regulation of cell cycle progression.…”
Section: Discussionmentioning
confidence: 96%